Literature DB >> 1746905

Chromosome and oncogene studies in human rectal and colon carcinomas.

D Rau1, A Köster, H Tittelbach, R Sachse, S Landgraf, S Neubauer, J Giedl, T Dingermann, E Gebhart.   

Abstract

Cytogenetic examinations of 48 rectal and 17 colon carcinomas and analyses of proto-oncogene activation on 67 of the former and 8 of the latter tumors were performed. Besides a general considerable heterogeneity of chromosome counts, some chromosomes were found to contribute non-randomly to hypersomies (# 2, 3, 7, 9, 19, 20 and 6) and to hyposomies (# 14, 15, Y, 21, and 18) in this material. Chromosomal markers non-randomly involved breakpoint clusters on 17p11, 13q11, 7p, 1p11, and 1p36 and on the centromeric regions of chromosomes 1, 8, 14, 15 and 21. Cytogenetic equivalents of gene amplification ("double minutes") were present in only rather small cell fractions (less than 20%) of 50% of the studied tumors. Using a cDNA technique and a battery of respective probes, proto-oncogene overexpression was screened for in the tumor samples, but also in 24 samples of inconspicuous mucosae of tumor patients and in two mucosae of healthy individuals. Simultaneous overexpression of several proto-oncogenes was the most characteristic finding in the tumor cells. However several of the mucosa samples obtained from tumor patients also just exhibited clear signals of proto-oncogene overexpression, which were not found in epithelial cells from non-tumor patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1746905

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Chromosome 1 in human colorectal tumors.

Authors:  E Gebhart; D Rau; S Neubauer; T Dingermann
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

2.  CYP2E1 RsaI/PstI polymorphisms contributed to oral cancer susceptibility: a meta-analysis.

Authors:  Yang Guo; Shan Zhou; Feng Liu; Bin Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  Cytogenetic, oncogenetic, and histopathologic characteristics of colorectal carcinomas with 17p abnormalities.

Authors:  D Rau; S Neubauer; A Köster; J Giedl; R Sachse; S Landgraf; A Leipold; T Dingermann; E Gebhart
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

4.  EPH-EPHRIN in human gastrointestinal cancers.

Authors:  Haruhiko Sugimura; Jian-Dong Wang; Hiroki Mori; Masaru Tsuboi; Kiyoko Nagura; Hisaki Igarashi; Hong Tao; Ritsuko Nakamura; Hiroko Natsume; Tomoaki Kahyo; Kazuya Shinmura; Hiroyuki Konno; Yasushi Hamaya; Shigeru Kanaoka; Hideki Kataoka; Xiao-Jun Zhou
Journal:  World J Gastrointest Oncol       Date:  2010-12-15

5.  Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas.

Authors:  C W Schweinfest; K W Henderson; S Suster; N Kondoh; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

6.  Pericentromeric regions are refractory to prompt repair after replication stress-induced breakage in HPV16 E6E7-expressing epithelial cells.

Authors:  Wen Deng; Sai Wah Tsao; Xin-Yuan Guan; Annie L M Cheung
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

7.  Cytogenetic studies in lymphocytes of patients with rectal cancer.

Authors:  E Gebhart; R Romahn; A Schneider; M Hoffmann; D Rau; H Tittelbach
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.